People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Biotech / Pharma, Healthtech, Other Technology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Manus Bio Inc. | — | Biotech / Pharma | Series C | $118.0M | $108.4M | 2017 |
| GNS Healthcare, Inc. | — | Healthtech | Series B | $56.5M | $562.3M | 2013 |
| Via Science, Inc. | — | Other Technology | Series B | $51.2M | $174.2M | 2016 |
| UniPolar Technology Inc. | — | Software / Tech | Seed | $2.2M | $73.6M | 2017 |
COLIN GOUNDEN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside COLIN GOUNDEN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Raymond Chang | 1 | 10 |
| Jeff Anderson | 1 | 8 |
| Adam Jackson | 1 | 7 |
| Richard Goldstein | 1 | 5 |
| Carsten Boers | 1 | 5 |
| Jason Whaley | 1 | 4 |
| Kripa Varanasi | 1 | 4 |
| Kasper Sage | 1 | 4 |
| DAVID BURKE | 1 | 3 |
| Mark Pottle | 1 | 3 |
| JAN BERGER | 1 | 3 |
| IYA KHALIL | 1 | 3 |
| Gregory Stephanopoulos | 1 | 2 |
| THOMAS NEYARAPALLY | 1 | 2 |
| Danny Cotter | 1 | 2 |
| Duncan McFarland | 1 | 2 |
| Rick Gerson | 1 | 2 |
| COLIN HILL | 1 | 2 |
| JIM L. DUTTON | 1 | 1 |
| BILL L. THORNBURG | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.